Reuters logo
BRIEF-Creso Pharma ‍Signs Exclusive Commercialization Agreement With Swiss Doetsch Grether​
December 3, 2017 / 10:24 PM / 11 days ago

BRIEF-Creso Pharma ‍Signs Exclusive Commercialization Agreement With Swiss Doetsch Grether​

Dec 4 (Reuters) - Creso Pharma Ltd:

* ‍SIGNS EXCLUSIVE COMMERCIALIZATION AGREEMENT WITH SWISS PHARMA COMPANY DOETSCH GRETHER​

* ‍OBTAINED NECESSARY APPROVALS TO MARKET ITS HEMP BASED NUTRACEUTICAL CANNAQIX IN SWITZERLAND​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below